Korean drugmakers control more than half of European biosimilar market
South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...
Hahn & Co. buys SK Enpulse’s chip wafer polishing pad business
Seoul-based private equity firm Hahn & Co. has agreed to buy the chemical mechanical polishing (CMP) pads manufacturing division of SK Enpulse C...
Hahn & Co. to buy controlling stake in SK’s specialty gas unit for $1.9 bn
South Korea’s private equity firm Hahn & Co. is set to acquire a controlling stake in the world’s top specialty gas producer SK Spec...
SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines
South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...
Celltrion obtains approval of Steqeyma from FDA
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
Celltrion BioSolutions launched to venture into CDMO
Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...
Celltrion’s 4 new biosimilars win EU approval recommendation
Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...
Celltrion to allot cash, stock dividend at once
South Korea’s biosimilar maker Celltrion Inc. on Friday announced a plan to allot cash and stock dividends simultaneously. The company wi...
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Boryung invests $10 million in Intuitive Machines
South Korea's Boryung Corp. said on Friday it bought $10.0 million in shares of US-based lunar lander company Intuitive Machines to expand its space...
Celltrion to retire $400 mn treasury stock in January
South Korea’s biosimilar maker Celltrion Inc. on Wednesday announced a plan to retire about a quarter of its treasury stock worth 563 billion ...
Bespin Global, Upstage to co-work on AI platform
South Korea's cloud solution provider Bespin Global said on Monday it signed with Upstage, the domestic artificial intelligence (AI) startup, to bui...
Celltrion to break ground on CDMO plant in 2025: Chairman Seo
South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (...
Samsung reshuffles top brass; Co-CEO to control memory business
Samsung Electronics Co., the world’s No. 1 memory chipmaker, reshuffled its leadership on Wednesday in a sweeping move as it faces an uph...
Korea Zinc, Hanwha to co-work on Austrailian BESS project
Korea Zinc Inc., the world’s top lead and zinc smelter, said on Tuesday its Australian subsidiary Ark Energy selected Hanwha Corp. as the pref...
Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug
Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...
Celltrion to acquire additional $72 mn in treasury shares
South Korea's Celltrion Inc. announced on Thursday that it decided to repurchase additional treasury shares worth 100 billion won ($71.6 million).Fr...
Celltrion acquires Swiss pharmaceutical distributor iQone
South Korea's Celltrion Inc. said on Friday that it completed its acquisition of iQone Healthcare Switzerland, a Swiss pharmaceutical distributor, t...
KEPCO, LS Electric to co-work on predictive diagnostics solutions
Korea Electric Power Corp. (KEPCO), the South Korean state-run utility company, said on Thursday it signed a memorandum of understanding (MOU) with ...
MSCI Korea Index adds Hyundai Rotem
MSCI announced on Wednesday that South Korea's Hyundai Rotem Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index. ...
Celltrion releases Steqeyma in Europe
South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...
HD Hyundai, Amogy, SK to co-work on ammonia-hydrogen power
South Korea's HD Hyundai Infracore Co. said on Monday it partnered with Amogy Inc., a US-based ammonia-powered systems developer, and SK Innova...
DevSisters, VNG Games sign Cookie Run Asia publishing deal
South Korean game developer DevSisters Corp. said on Friday that it signed a publishing agreement with Vietnamese game company VNG Games for "Cookie...
Celltrion's Zymfentra gets 90% distribution channel in US
South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...
Kakao Mobility, Samsung C&T to co-work on robot, parking solutions
Kakao Mobility Corp., South Korea’s largest taxi-hailing app operator, announced on Friday that it signed a business agreement with Samsung C&...
Celltrion to establish CDMO subsidiary
Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...
LG Elec to advance in-cabin sensing solution
LG Electronics Inc. said on Monday it's advancing its in-cabin sensing solution which detects and analyzes the interior of vehicles to prevent acc...
Celltrion's anti cancer drugs hold 90% market share in C.America
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
LG NOVA hosts Innovation Festival in US
LG Electronics Inc. 's North American Innovation Center (LG NOVA) said on Monday that it held an Innovation Festival last Wednesday and Thursday at ...
Celltrion establishes subsidiary in Vietnam
Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....
